Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000312478 | SCV000339690 | pathogenic | not provided | 2016-03-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001213324 | SCV001384950 | uncertain significance | Myopathy, centronuclear, 2 | 2020-03-24 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change affects a donor splice site in intron 15 of the BIN1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with BIN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 286314). The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in BIN1 cause disease. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant is present in population databases (rs556129959, ExAC 0.1%). |